RESEARCH &
DEVELOPMENT

Research & Development Overview

ACI HealthCare Limited’s Research and Development function is focused on the scientific design and development of high-quality generic pharmaceutical products for regulated and emerging markets. Our R&D strategy is built on a structured, science-based approach that ensures products are developed with a clear understanding of quality, performance, and regulatory expectations from the earliest stages.

Development activities are guided by Quality-by-Design (QbD) principles, integrating formulation science, process understanding, and risk-based evaluation to achieve robust and reproducible outcomes. From feasibility and formulation development to scale-up and technology transfer, each stage is managed within a controlled framework that emphasizes consistency, efficiency, and lifecycle quality.

Our R&D organization is structured across formulation development, analytical development, and supporting quality functions, ensuring that products are developed with strong scientific justification and validated analytical methods. Stability studies, method validation, and regulatory documentation are conducted in alignment with international guidelines, supporting successful submissions in regulated markets.

Our Capabilities

ACI HealthCare Limited specializes in the development and manufacturing of oral solid dosage (OSD) pharmaceutical products, supported by advanced processing technologies, formulation expertise, and compliant manufacturing systems. Our capabilities are designed to address a wide spectrum of product requirements, from conventional dosage forms to more complex and differentiated generic formulations.

Pharmaceutical manufacturing equipment and processing vessels

Manufacturing
Strengths

Our manufacturing platform integrates modern processing technologies and controlled production environments to ensure consistent quality, scalability, and operational efficiency.

Formulation &
Technology Platforms

Our formulation development capabilities support a diverse range of delivery systems designed to optimize drug release, stability, and patient compliance.

Operators in a controlled cleanroom production environment

Technology Transfer & Global Generic Integration

ACI HealthCare Limited operates as a globally aligned generic pharmaceutical manufacturer, with the capability to support product development and commercialization in accordance with regulated-market requirements. Our systems and processes are designed to integrate seamlessly with regulatory pathways such as ANDA and EU dossier frameworks, ensuring consistent execution from development through commercial supply.

We maintain a structured approach to technology transfer that emphasizes process understanding, risk-based scale-up, and lifecycle validation, ensuring that products are manufactured in full alignment with defined critical quality attributes (CQAs) and critical process parameters (CPPs). Cross-functional integration across R&D, Manufacturing, Quality, and Regulatory Affairs enables efficient translation of development knowledge into robust commercial processes.

This integrated capability positions ACI HealthCare as a reliable partner for global generic product development, dossier-driven manufacturing, and regulated-market supply, supporting long-term collaboration and sustainable access to medicines worldwide.

Our operational model supports both internally developed products and externally partnered programs, enabling flexible collaboration with global pharmaceutical companies. Through disciplined documentation practices, data integrity frameworks, and validated systems, we ensure that all transferred and developed products meet international expectations for quality, consistency, and regulatory compliance.

Why Partner with AHL

Regulatory Alignment

Built on globally accepted frameworks, ensuring compliance with US, EU, and international regulatory expectations

Integrated Capabilities

Seamless coordination across development, manufacturing, quality, and regulatory functions for efficient execution

Data Integrity & Transparency

Digitally enabled systems ensuring traceability, audit readiness, and trusted data throughout the product lifecycle

Scalable Manufacturing

Flexible, high-capacity production platform supporting consistent supply and multi-market demand

Scientific & Technical Expertise

Strong formulation and process understanding enabling robust, reproducible generic products

Reliable Partnership Model

Commitment to long-term collaboration through disciplined execution, responsiveness, and shared success

RESEARCH &DEVELOPMENT